All Stories

  1. Chimeric virus-like particles containing influenza HA antigen and GPI-CCL28 induce long-lasting mucosal immunity against H3N2 viruses

    Article • Scientific Reports, January 2017, Nature

    Dr. Teena Mohan

  2. Coated protein nanoclusters from influenza H7N9 HA are highly immunogenic and induce robust protective immunity

    Article • Nanomedicine Nanotechnology Biology and Medicine, January 2017, Elsevier

    Dr. Teena Mohan

  3. Coexistence of Th1/Th2 and Th17/Treg imbalances in patients with post traumatic sepsis

    Article • Cytokine, December 2016, Elsevier

    Dr. Teena Mohan

  4. Co-delivery of GPI-anchored CCL28 and influenza HA in chimeric virus-like particles induces cross-protective immunity against H3N2 viruses

    Article • Journal of Controlled Release, July 2016, Elsevier

    Dr. Teena Mohan

  5. Evaluation of Multiple Antigenic Peptides Based on the Chikungunya E2 Protein for Improved Serological Diagnosis of Infection

    Article • Viral Immunology, March 2015, Mary Ann Liebert Inc

    Dr. Teena Mohan

  6. Current understanding of HIV-1 and T-cell adaptive immunity: Progress to date

    Article • Microbial Pathogenesis, August 2014, Elsevier

    Dr. Teena Mohan

  7. Comparative mucosal immunogenicity of HIV gp41 membrane-proximal external region (MPER) containing single and multiple repeats of ELDKWA sequence with defensin peptides

    Article • Immunobiology, April 2014, Elsevier

    Dr. Teena Mohan

  8. A synthetic chimeric peptide harboring human papillomavirus 16 cytotoxic T lymphocyte epitopes shows therapeutic potential in a murine model of cervical cancer

    Article • Immunologic Research, October 2013, Springer Science + Business Media

    Dr. Teena Mohan

  9. Nasal delivery of PLG microparticle encapsulated defensin peptides adjuvanted gp41 antigen confers strong and long-lasting immunoprotective response against HIV-1

    Article • Immunologic Research, May 2013, Springer Science + Business Media

    Dr. Teena Mohan

  10. Modulation of HIV peptide antigen specific cellular immune response by synthetic α- and β-defensin peptides

    Article • Vaccine, March 2013, Elsevier

    Dr. Teena Mohan, nageswararao donthamsetty

  11. Current practices in laboratory monitoring of HIV infection

    Article • The Indian Journal of Medical Research, January 2011, Medknow

    Dr. Teena Mohan

  12. Induction of Cell-Mediated Immune Responses to Peptide Antigens ofP. vivaxin Microparticles Using Intranasal Immunization

    Article • Immunological Investigations, January 2010, Taylor & Francis

    Dr. Teena Mohan

  13. Intranasal administration of peptide antigens of HIV with mucosal adjuvant CpG ODN coentrapped in microparticles enhances the mucosal and systemic immune responses

    Article • International Immunopharmacology, April 2009, Elsevier

    Dr. Teena Mohan